Developing a vaccine to protect against cryptococcal infections in AIDS patients
Cryptococcal vaccine development based on strong immunity induced by morphological strains
This study is working on a vaccine to help prevent a serious fungal infection called cryptococcal meningoencephalitis in people with AIDS by figuring out how a harmless version of the fungus can boost their immune system to fight off infections better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11079639 on NIH RePORTER |
What this research studies
This research focuses on creating a vaccine to prevent cryptococcal meningoencephalitis, a severe fungal infection that significantly affects AIDS patients. The team is investigating how different forms of the fungus Cryptococcus neoformans interact with the immune system, particularly how a specific transcription factor can enhance protective immunity. By using a non-pathogenic form of the fungus, they aim to stimulate a strong immune response that could protect individuals, even those with weakened immune systems, from severe infections. The research involves laboratory models that mimic the immune conditions of AIDS patients to test the vaccine's effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV/AIDS who are at risk of developing cryptococcal infections.
Not a fit: Patients who do not have HIV/AIDS or those who are not at risk for cryptococcal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that dramatically reduces the mortality rate from cryptococcal infections in AIDS patients.
How similar studies have performed: Previous research has shown promising results in using similar approaches to develop vaccines against fungal infections, indicating potential for success in this area.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Lin, Xiaorong — University of Georgia
- Study coordinator: Lin, Xiaorong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.